1.
Arch. pediatr. Urug
;
92(nspe1): e805, jun. 2021.
Article
in Spanish
| LILACS, BNUY, UY-BNMED
| ID: biblio-1278315
2.
Med. infant
;
21(2): 154-162, Junio 2014. tab, ilus
Article
in Spanish
| LILACS
| ID: biblio-913409
Subject(s)
Humans , Child , Adolescent , Adult , Papillomavirus Infections/prevention & control , Papillomavirus Infections/epidemiology , Papillomavirus Vaccines/administration & dosage , Papillomavirus Vaccines/classification , Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 , Argentina/epidemiology , Immunocompromised Host
3.
Einstein (Säo Paulo)
;
11(4): 547-549, out.-dez. 2013.
Article
in Portuguese
| LILACS, SES-SP
| ID: lil-699874
ABSTRACT
A infecção pelo papilomavírus humano é comum e produz manifestações diversas. Essa infecção adquire importância para saúde pública, pois tem sido associada a malignidades do trato genital em homens e mulheres. Atualmente, temos disponíveis duas vacinas para prevenção da infecção pelo papilomavírus humano e, consequentemente, de doenças a ele associadas.
Human papillomavirus infection is common and causes different manifestations. This infection is a public health concern because it has been associated with genital tract malignant diseases among men and women. Currently two vaccines are available to prevent the human papillomavirus infection and its associated diseases.